fibrinolytic agents

Preferred Label : fibrinolytic agents;

MeSH definition : Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.;

MeSH synonym : fibrinolytic drugs; thrombolytic drugs; thrombolytic agents; Fibrinolytic Drug; Drug, Fibrinolytic; Thrombolytic Drug; Drug, Thrombolytic; Fibrinolytic Agent; Agent, Fibrinolytic; Thrombolytic Agent; Agent, Thrombolytic;

Related MeSH term : antithrombotic agents; Antithrombic Drugs; Agents, Antithrombotic; Drugs, Antithrombic; Antithrombotic Agent; Agent, Antithrombotic; Antithrombic Drug; Drug, Antithrombic;

Wikipedia link : https://en.wikipedia.org/wiki/Thrombolytic drug;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D005343;

UMLS CUI

C0016018;

ATC code(s)
- alteplase [ATC Code]
- antithrombotic agents [ATC Code]
- antithrombotic agents [ATC Code]
- heparin, combinations [ATC Code]
- other antithrombotic agents [ATC Code]
- protein c [ATC Code]
- streptokinase [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Fibrinolytic drug [ICD-11 Extension code]
Indexing information
- (1alpha,4abeta,8aalpha)-1-isopropanol-4a-methyl-8-methylenedecahydronaphthalene [MeSH Supplementary Concept]
- 2-(benzyl(2-((4-carbamimidoylphenoxy)methyl)-2,3-dihydro-1,4-benzodioxin-6-yl)amino)-2-oxoacetic acid [MeSH Supplementary Concept]
- 2-acetylphenothiazine [MeSH Supplementary Concept]
- 5-chlorothiophene-2-carboxylic acid (2-(2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino)-3-(4-methylpiperazin-1-yl)-3-oxopropyl)amide [MeSH Supplementary Concept]
- HN 11500 [MeSH Supplementary Concept]
- Rosiglitazone [MeSH Descriptor]
- Troglitazone [MeSH Descriptor]
- UFEII protein, urechis unicinctus [MeSH Supplementary Concept]
- astaxanthine [MeSH Supplementary Concept]
- caplacizumab [MeSH Supplementary Concept]
- crinumin, crinum asiaticum [MeSH Supplementary Concept]
- drotrecogin alfa activated [MeSH Supplementary Concept]
- ferric chloride [MeSH Supplementary Concept]
- herinase, hericium erinaceum [MeSH Supplementary Concept]
- ilexonin A [MeSH Supplementary Concept]
- ixophilin protein, Ixodes scapularis [MeSH Supplementary Concept]
- semuloparin [MeSH Supplementary Concept]
- sulnate [MeSH Supplementary Concept]
- tetramethylpyrazine [MeSH Supplementary Concept]
- threo-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol [MeSH Supplementary Concept]
Ne pas confondre avec
- fibrinolysis [MeSH Descriptor]
Record concept(s)
- antithrombotic agents [MeSH concept]
- fibrinolytic agents [MeSH concept]
Related MeSH term(s)
- antifibrinolytic agents [MeSH Descriptor]
See also (suggested by CISMeF)
- anticoagulants [MeSH Descriptor]
- antifibrinolytic agents [MeSH Descriptor]
- thrombolytic therapy [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 9-O-methanoprostaglandin I [MeSH Supplementary Concept]
- Cilostazol [MeSH Descriptor]
- PENTA [MeSH Supplementary Concept]
- SR 46349B [MeSH Supplementary Concept]
- Tenecteplase [MeSH Descriptor]
- Tinzaparin [MeSH Descriptor]
- Tirofiban [MeSH Descriptor]
- WEB 2086 [MeSH Supplementary Concept]
- Y 20811 [MeSH Supplementary Concept]
- abietic acid [MeSH Supplementary Concept]
- acetylphenylalanyl-prolyl-boroarginine [MeSH Supplementary Concept]
- amylase, phosphates, proteases drug combinations [MeSH Supplementary Concept]
- anagrelide [MeSH Supplementary Concept]
- ancrod [MeSH Descriptor]
- anistreplase [MeSH Descriptor]
- aprosulate [MeSH Supplementary Concept]
- ardeparin [MeSH Supplementary Concept]
- asarone [MeSH Supplementary Concept]
- aspirin [MeSH Descriptor]
- batroxobin [MeSH Descriptor]
- benzarone [MeSH Supplementary Concept]
- brinolase [MeSH Descriptor]
- calcium heparin [MeSH Supplementary Concept]
- dalteparin [MeSH Descriptor]
- dan-shen root extract [MeSH Supplementary Concept]
- danaparoid [MeSH Supplementary Concept]
- defibrotide [MeSH Supplementary Concept]
- desirudin [MeSH Supplementary Concept]
- ecarin [MeSH Supplementary Concept]
- enoxaparin [MeSH Descriptor]
- fibrin destabilase [MeSH Supplementary Concept]
- fibrinolysin [MeSH Descriptor]
- ginkgolide B [MeSH Supplementary Concept]
- glucuronyl glucosamine glycan sulfate [MeSH Supplementary Concept]
- heparin [MeSH Descriptor]
- heparin, low-molecular-weight [MeSH Descriptor]
- higenamine [MeSH Supplementary Concept]
- hirudins [MeSH Descriptor]
- isbogrel [MeSH Supplementary Concept]
- kistrin [MeSH Supplementary Concept]
- lepirudin [MeSH Supplementary Concept]
- lipoprotein-associated coagulation inhibitor [MeSH Supplementary Concept]
- monteplase [MeSH Supplementary Concept]
- nadroparin [MeSH Descriptor]
- nafazatrom [MeSH Supplementary Concept]
- nitroaspirin [MeSH Supplementary Concept]
- ozagrel [MeSH Supplementary Concept]
- pamiteplase [MeSH Supplementary Concept]
- parnaparin [MeSH Supplementary Concept]
- plasminogen [MeSH Descriptor]
- protein C [MeSH Descriptor]
- reteplase [MeSH Supplementary Concept]
- reviparin [MeSH Supplementary Concept]
- salivary plasminogen activator alpha 1, Desmodus rotundus [MeSH Supplementary Concept]
- sarpogrelate [MeSH Supplementary Concept]
- saruplase [MeSH Supplementary Concept]
- semuloparin [MeSH Supplementary Concept]
- snake venom protein C activator [MeSH Supplementary Concept]
- streptokinase [MeSH Descriptor]
- sulotroban [MeSH Supplementary Concept]
- ticlopidine [MeSH Descriptor]
- tissue plasminogen activator [MeSH Descriptor]
- vapiprost [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Fibrinolytic drug [ICD-11 Extension code]
- Medicinal product acting as thrombolytic agent (product) [SNOMED CT concept]
- Thrombolytic [LOINC part]
- Thrombolytic Agent [NCIt concept]
- Thrombolytic agent (substance) [SNOMED CT concept]
- Thrombolytic drug [Bloc CIM-11]
- thrombolytic agent, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients